{"log_id": 4634779705082413913, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 3.5e-05, "average": 0.994474, "min": 0.982255}, "location": {"width": 163, "top": 118, "height": 30, "left": 193}, "words": "药物相互作用】"}, {"probability": {"variance": 6.9e-05, "average": 0.995845, "min": 0.965048}, "location": {"width": 812, "top": 167, "height": 39, "left": 218}, "words": "本品与肝脏细胞色素P450酶的亲和力较低,并有Ⅱ期代谢的途径,因而与通过细胞色素"}, {"probability": {"variance": 7.9e-05, "average": 0.995973, "min": 0.955583}, "location": {"width": 552, "top": 215, "height": 34, "left": 188}, "words": "P450酶系代谢的其他药物相互作用较奥美拉唑和兰索拉唑少"}, {"probability": {"variance": 4e-06, "average": 0.99808, "min": 0.993945}, "location": {"width": 112, "top": 293, "height": 28, "left": 195}, "words": "【药物过量】"}, {"probability": {"variance": 4e-06, "average": 0.99838, "min": 0.993994}, "location": {"width": 320, "top": 344, "height": 27, "left": 211}, "words": "未进行该项试验且无可靠参考文献"}, {"probability": {"variance": 0, "average": 0.999266, "min": 0.998042}, "location": {"width": 118, "top": 423, "height": 25, "left": 192}, "words": "【药理毒理】"}, {"probability": {"variance": 0, "average": 0.999751, "min": 0.999505}, "location": {"width": 89, "top": 472, "height": 25, "left": 209}, "words": "药理作用"}, {"probability": {"variance": 0.000946, "average": 0.990867, "min": 0.81484}, "location": {"width": 843, "top": 517, "height": 41, "left": 183}, "words": "泮托拉唑为质子泵抑制剂,通过与胃壁细胞的H-KATP酶系统的两个位点共价结合而抑制胃"}, {"probability": {"variance": 0, "average": 0.907494, "min": 0.907494}, "location": {"width": 21, "top": 548, "height": 19, "left": 457}, "words": "注"}, {"probability": {"variance": 0.001875, "average": 0.988854, "min": 0.740414}, "location": {"width": 844, "top": 564, "height": 45, "left": 183}, "words": "酸产生的最后步骤:该作用呈剂量依赖性并使基础和刺激状态下的胃酸分泌均受抑制。本品"}, {"probability": {"variance": 0.001056, "average": 0.985525, "min": 0.836174}, "location": {"width": 561, "top": 618, "height": 33, "left": 185}, "words": "与H-KATP酶的结合可导致其抗胃酸分泌作用持续24小时以上"}, {"probability": {"variance": 0, "average": 0.999771, "min": 0.999473}, "location": {"width": 86, "top": 667, "height": 25, "left": 184}, "words": "毒理研究"}, {"probability": {"variance": 0, "average": 0.999858, "min": 0.999581}, "location": {"width": 88, "top": 716, "height": 26, "left": 182}, "words": "遗传毒性"}, {"probability": {"variance": 7e-06, "average": 0.998473, "min": 0.989239}, "location": {"width": 842, "top": 762, "height": 39, "left": 180}, "words": "泮托拉唑的人淋巴细胞染色体畸变试验、中国仓鼠卵巢细胞/ /HGPRT正向突变试验及二次小鼠"}, {"probability": {"variance": 0.000606, "average": 0.994444, "min": 0.838886}, "location": {"width": 817, "top": 810, "height": 40, "left": 181}, "words": "微核试验中的一次结果均为阳性,而大鼠肝脏DNA共价结合试验结果难以判断。Ames试验"}, {"probability": {"variance": 0.000556, "average": 0.991964, "min": 0.839622}, "location": {"width": 840, "top": 859, "height": 40, "left": 181}, "words": "大鼠肝细胞程序外DNA合成试验(UDS)、AS52/GPT哺乳动物细胞正向基因突变试验、小鼠淋巴"}, {"probability": {"variance": 1.9e-05, "average": 0.998007, "min": 0.977924}, "location": {"width": 808, "top": 908, "height": 38, "left": 180}, "words": "瘤L5178Y细胞胸腺嘧啶激酶突变试验及体内大鼠骨髓细胞染色体畸变试验结果均为阴性"}, {"probability": {"variance": 0, "average": 0.999831, "min": 0.999603}, "location": {"width": 86, "top": 959, "height": 24, "left": 179}, "words": "生殖毒性"}, {"probability": {"variance": 0.009577, "average": 0.966133, "min": 0.479982}, "location": {"width": 844, "top": 1005, "height": 42, "left": 176}, "words": "雄性大鼠经口给予泮托拉唑500mg/kg/d(按体表面积折算为临床推荐口服剂量的98倍),雌"}, {"probability": {"variance": 0.000504, "average": 0.991681, "min": 0.853626}, "location": {"width": 838, "top": 1055, "height": 40, "left": 177}, "words": "性大鼠经口给予泮托拉唑450mg/kg/d(按体表面积折算为临床推荐口服剂量的88倍)时,生"}, {"probability": {"variance": 1e-06, "average": 0.999487, "min": 0.997093}, "location": {"width": 279, "top": 1104, "height": 32, "left": 177}, "words": "育力及生殖行为未见明显异常"}, {"probability": {"variance": 0.007924, "average": 0.97032, "min": 0.466094}, "location": {"width": 840, "top": 1151, "height": 42, "left": 175}, "words": "雄性大鼠经口给予泮托拉唑450mg/kg/d,家兔经口给予泮托拉唑40mg/k按体表面积折"}, {"probability": {"variance": 0.000736, "average": 0.988913, "min": 0.888984}, "location": {"width": 842, "top": 1194, "height": 53, "left": 174}, "words": "算为临床推荐口服剂量的16倍对育力和胎仔均未见明显损害。泮托拉代谢产物"}, {"probability": {"variance": 3e-06, "average": 0.998582, "min": 0.994296}, "location": {"width": 216, "top": 1252, "height": 30, "left": 173}, "words": "可以从家兔乳汁中分泌"}, {"probability": {"variance": 0, "average": 0.999744, "min": 0.999459}, "location": {"width": 66, "top": 1303, "height": 25, "left": 172}, "words": "致癌性"}, {"probability": {"variance": 0.012216, "average": 0.958964, "min": 0.444334}, "location": {"width": 841, "top": 1351, "height": 41, "left": 173}, "words": "SD大鼠连续24个月经口给子泮挽拉唑0.5-200mg/kg/d,胃底出现剂量依赖性的肠嗜铬样细胞"}, {"probability": {"variance": 0.006614, "average": 0.983189, "min": 0.454197}, "location": {"width": 839, "top": 1400, "height": 39, "left": 170}, "words": "增生及良性和恶性的神经内分泌细胞瘤.当剂量为50和200mg/kg/d(按体表面积折算为临床"}, {"probability": {"variance": 9e-05, "average": 0.996772, "min": 0.939673}, "location": {"width": 838, "top": 1449, "height": 38, "left": 169}, "words": "推荐口服剂量的10和40倍)时,前胃出现良性鳞状细胞乳头状瘤和恶性鳞状细胞癌。泮托拉"}, {"probability": {"variance": 5.4e-05, "average": 0.997531, "min": 0.953897}, "location": {"width": 838, "top": 1496, "height": 40, "left": 169}, "words": "唑还导致极少数大鼠出现胃肠道肿瘤,包括50mg/kg/d剂量时偶尔出现十二指肠腺癌,以及"}], "language": 3}